From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
Michael Nassif, MD, MSc
Anjali Owens, MD
Modern Obstructive HCM Care: From Unmet Needs to Individualized Myosin Inhibitor Therapy
Ahmad Masri, MD, MS
From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA
Nihar R. Desai, MD, MPH
Kappa-Opioid Settings: Real-World Evidence Insights
Lucio Manenti, MD, PhD
Emilio Sanchez, MD, PhD
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
James Burton, DM, FRCP
Leonie Kraft, MD
The Patient-Clinician Connection in Managing CKD-aP
CKD-aP Treatment Tool Kit
Improving Sleep and Mental Health in Patients with CKD-aP
CKD-aP: Beyond the Surface
Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
An De Vriese, MD, PhD
Muh Geot Wong, MBBS, PhD
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
Patrick Rossignol, MD, PhD
Potassium Binders: Safety Comes First!
Javed Butler, MD, MPH, MBA
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
Javed Butler, MD
Potassium Binders in Practice: Clinical Trial Evidence